Renuvion Wins Second Consecutive NewBeauty Award for Minimally Invasive Skin Tightening
Event summary
- Renuvion, a product of Apyx Medical Corporation, won the 2026 NewBeauty Award for 'Best Minimally Invasive Skin Tightener' for the second consecutive year.
- The award highlights Renuvion's FDA clearance for use following liposuction, enhancing body contouring capabilities.
- Renuvion is now combined with the AYON platform, streamlining workflows and increasing procedural efficiency.
- 4 out of 5 surgeons agree Renuvion is the #1 trusted body contouring technology, based on a 2024 survey by Wakefield Research.
The big picture
Renuvion's consecutive award win underscores its dominance in the minimally invasive skin tightening market. The integration with the AYON platform positions Apyx Medical to capture a larger share of the aesthetic surgery sector, which is increasingly valuing non-invasive and minimally invasive procedures. The company's strategic focus on physician trust and procedural efficiency aligns with broader industry trends toward personalized and efficient aesthetic solutions.
What we're watching
- Market Expansion
- How the integration of the AYON platform will affect Renuvion's market penetration and procedural efficiency.
- Competitive Positioning
- Whether Apyx Medical can sustain its leadership in minimally invasive body contouring amid growing competition.
- Regulatory Compliance
- The pace at which Renuvion's FDA-cleared applications will expand, potentially opening new market segments.
Related topics